Menu
GWAS Study

Genetic analysis in African American children supports ancestry specific neuroblastoma susceptibility.

Testori A, Vaksman Z, Diskin SJ et al.

35131881 PubMed ID
GWAS Study Type
3619 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

TA
Testori A
VZ
Vaksman Z
DS
Diskin SJ
HH
Hakonarson H
CM
Capasso M
IA
Iolascon A
MJ
Maris JM
DM
Devoto M
Chapter II

Abstract

Summary of the research findings

Neuroblastoma is rarer in African American (AA) children compared with American children of European descent. AA children affected with neuroblastoma, however, more frequently develop the high-risk form of the disease.

629 African American cases, 2,990 African American controls

Chapter III

Study Statistics

Key metrics and study information

3619
Total Participants
GWAS
Study Type
No
Replicated
African American or Afro-Caribbean
Ancestry
U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.